Geneva, June 8 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125760) titled 'Low-Dose Cyclosporine Combined with Eltrombopag in Patients with Primary Immune Thrombocytopenia Refractory or Dependent to First-Line Glucocorticoid Treatment' on May 31.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University
Condition:
primary immune thrombocytopenia
Intervention:
Control group:Eltrombopag
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-31
Target Sample Size: Control group:47;Experimental group:47;
Countries of Recruitment:
China
To know more, visit https://www...